Hospitals held the strongest position in the vascular access devices market in 2025, accounting for a 52.71% share. This leadership is underpinned by the concentration of acute care, critical care, surgical procedures, and inpatient treatment pathways that require consistent and high-volume vascular access device usage. Hospitals also manage a broad mix of patients needing short-term and complex infusion therapy, blood sampling, and medication delivery, which keeps demand structurally higher than in other end-use settings across the vascular access devices market.

Ambulatory Care Centers are the fastest-growing segment in the vascular access devices market as care delivery continues shifting toward outpatient environments that prioritize procedural efficiency and shorter patient stays. Their momentum is supported by the rising suitability of these centers for infusion-related treatments and minor interventions that still require dependable vascular access without the resource intensity of hospital admission. Compared with traditional inpatient settings, Ambulatory Care Centers benefit from operating models built around faster turnover and lower-cost care delivery, which is strengthening adoption of vascular access devices in this segment.

Product Segment Analysis: Short Peripheral Intravenous Catheter (Short PIVCs) (Largest Segment) vs Midline Catheters (Fastest-Growing Segment)

In 2025, Short Peripheral Intravenous Catheter (Short PIVCs) led the vascular access devices market with a 46.64% share. Their position is anchored in routine, widespread use across everyday clinical care, where they serve as a standard option for short-duration fluid administration, medication delivery, and general bedside access needs. Because they fit a large volume of common hospital and outpatient procedures, Short Peripheral Intravenous Catheter (Short PIVCs) maintain strong utilization across the vascular access devices market and remain the default choice in many first-line access situations.

Midline Catheters are emerging as the fastest-growing product segment in the vascular access devices market due to increasing demand for access options that better align with intermediate-duration therapy requirements. Their growth is being driven by practical clinical needs that fall between short peripheral use and more invasive central access, making them an appealing alternative when longer dwell times are needed without moving to central venous placement. Relative to other device types, Midline Catheters are gaining traction because they support a more balanced approach to therapy duration and patient management in evolving care settings.